This inventor holds 6 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Columbia University. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Florence Borot: Innovator in Hematological Research
Introduction
Florence Borot is a distinguished inventor based in New York, NY (US), known for her significant contributions to the field of immunotherapy for hematological malignancies. With a total of 6 patents, she has made remarkable strides in developing innovative solutions that target specific cell-surface antigens.
Latest Patents
Her latest patents include groundbreaking work on "CD33 exon 2 deficient donor stem cells for use with CD33 targeting agents." This patent discloses compositions and methods related to agents that target a lineage-specific cell-surface antigen and a population of hematopoietic cells deficient in this antigen for immunotherapy purposes. Another notable patent is focused on "Compositions and methods for inhibition of lineage-specific antigens," which outlines methods for administering agents that target lineage-specific cell-surface antigens, further advancing the field of hematological treatments.
Career Highlights
Florence Borot is affiliated with Columbia University, where she continues her research and development efforts. Her work has been instrumental in enhancing the understanding and treatment of hematological malignancies, showcasing her dedication to improving patient outcomes through innovative therapies.
Collaborations
Florence has collaborated with notable professionals in her field, including Siddhartha Mukherjee and Abdullah Mahmood Ali. These partnerships have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Florence Borot stands out as a leading inventor in the realm of hematological research, with her patents paving the way for new therapeutic approaches. Her commitment to innovation and collaboration underscores her vital role in the scientific community.